Процентный доход Изменить Дата
argenx SE USD 42.7M 4.3M 2025-09
AstraZeneca USD 73M 62M 2026-03
Biogen USD 37.9M 700K 2026-03
Genmab DKK 25M 8M 2025-06
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
GRIFOLS EUR 9.56M 4.5M 2025-06
Hikma Pharmaceutical USD 4M 0 2024-12
Incyte USD 30.75M 3.97M 2025-12
Merck EUR 27M 10M 2025-09
Sanofi EUR 33M 81M 2025-12
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09